13F HOLDINGS REPORT
Caligan Partners LP
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0001727492-23-000009
Total Value
$177.8M
Positions
13
Other Managers
0
Confidential Omitted
No
Holdings (13)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | LIQUIDIA CORP | LQDA | 9,243,627 | $72.6M | 40.81% |
| 2 | ANIKA THERAPEUTICS INC | ANIK | 720,291 | $18.7M | 10.52% |
| 3 | EXELIXIS INC | EXEL | 910,730 | $17.4M | 9.79% |
| 4 | STANDARD BIOTOOLS INC | LAB | 8,467,920 | $16.3M | 9.19% |
| 5 | INTERCEPT PHARMACEUTICALS INC | INTR | 1,293,510 | $14.3M | 8.05% |
| 6 | INTERCEPT PHARMACEUTICALS INC | INTR | 1,200,000 | $13.3M | 7.46% |
| 7 | EVOLUS INC | EOLS | 1,760,136 | $12.8M | 7.20% |
| 8 | VERONA PHARMA PLC | 925050106 | 183,064 | $3.9M | 2.18% |
| 9 | ADMA BIOLOGICS INC | ADMA | 847,513 | $3.1M | 1.76% |
| 10 | EYEPOINT PHARMACEUTICALS INC | EYPT | 310,298 | $2.7M | 1.52% |
| 11 | ALIMERA SCIENCES INC | 016259202 | 478,777 | $1.4M | 0.79% |
| 12 | SOCIETAL CDMO INC | 75629F109 | 1,077,268 | $1.2M | 0.67% |
| 13 | AGIOS PHARMACEUTICALS INC | AGIO | 4,833 | $136,871 | 0.08% |